Skye Bioscience, Inc. Total Contract Liability
Skye Bioscience, Inc. (SKYE) had Total Contract Liability of $0 as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2024-11-07
- 2024-09-30: Contract with Customer, Liability $0.00.
- 2024-06-30: Contract with Customer, Liability $0.00.
- 2024-03-31: Contract with Customer, Liability $123.17K.
- 2023-12-31: Contract with Customer, Liability $180.90K.
| Period end | Contract with Customer, Liability |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 |
| 2024-03-31 | $123.17K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $180.90K 10-Q · filed 2024-11-07 |
| 2023-09-30 | $217.99K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $188.23K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $134.90K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $134.90K 10-Q · filed 2023-11-14 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |